WAM
GSK icon

Wolverine Asset Management’s GSK GSK Stock Holding History

Wolverine Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-32
Closed -$37K – 1784
2015
Q3 		$37K Buy
+32
New +$1.67K ﹤0.01% 1338
2015
Q1 		– Sell
-46
Closed -$60K – 1974
2014
Q4 		$60K Sell
46
-8
-15% -$448 ﹤0.01% 1341
2014
Q3 		$56K Buy
54
+19
+54% +$1.17K ﹤0.01% 1496
2014
Q2 		$19K Sell
35
-52
-60% -$3.52K ﹤0.01% 1702
2014
Q1 		$27K Sell
87
-50
-36% -$3.38K ﹤0.01% 1537
2013
Q4 		$61K Buy
137
+52
+61% +$3.37K ﹤0.01% 1692
2013
Q3 		$71K Sell
85
-88
-51% -$5.67K ﹤0.01% 1594
2013
Q2 		$85K Buy
+173
New +$11K ﹤0.01% 1488

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wolverine Asset Management's GSK Position: Q4 2014 in Review

Wolverine Asset Management sold out of GSK (GSK) in Q4 2014, closing a stake of 3,440 shares — an estimated $192K sold.

Wolverine Asset Management first reported a position in GSK in Q2 2013 and held it in 6 quarters. The position peaked at $891K in Q4 2013. 728 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

  • Wolverine Asset Management reported no remaining GSK position as of Q4 2014 after selling out during the quarter.
  • Wolverine Asset Management sold 3,440 GSK shares in Q4 2014, an estimated $192K.
  • Wolverine Asset Management first reported a position in GSK in Q2 2013 and held it in 6 quarters.
  • Wolverine Asset Management's GSK position peaked at $891K in Q4 2013.
  • 728 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Wolverine Asset Management's 13F filing for Q4 2014, filed 12 Feb 2015.